Collplant Biotechnologies Ltd (NASDAQ:CLGN)
| 16.67 Delayed Data As of 4:10pm ET |  +0.03 / +0.18%Today’s Change | 6.00 Today|||52-Week Range 24.26 | +54.78% Year-to-Date |
Latest CLGN News | Press Releases
No recent news for Collplant Biotechnologies Ltd.
Today’s Trading
| Previous close | 16.64 |
| Today’s open | 16.78 |
| Day’s range | 16.50 - 16.79 |
| Volume | 310 |
| Average volume (3 months) | 40,606 |
| Market cap | $181.1M |
Data as of 4:10pm ET, 09/27/2021
Growth & Valuation
| Earnings growth (last year) | +62.55% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +164.75% |
| P/E ratio | 64.1 |
| Price/Sales | 12.09 |
| Price/Book | 27.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IVCInvacare Corp | +0.13 | +2.51% |
| EDAPEdap Tms SA | -0.04 | -0.64% |
| IINIntricon Corp | -0.36 | -1.78% |
| SRGASurgalign Holdings I... | -0.08 | -6.46% |
Data as of 4:15pm ET, 09/27/2021
Financials
| Next reporting date | November 26, 2021 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $6.1M |
| Annual profit (last year) | -$5.8M |
| Net profit margin | -94.09% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Rehovot, Tel Aviv |
Forecasts
